BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38580573)

  • 1. Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer.
    Huang JX; Chen YJ; Wang XY; Huang JH; Gan KH; Tang LN; Pei XQ
    Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38580573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
    Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
    Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.
    Kim JY; Park HS; Kim S; Ryu J; Park S; Kim SI
    Medicine (Baltimore); 2015 Oct; 94(43):e1720. PubMed ID: 26512562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
    Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
    Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
    Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
    Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
    Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer.
    Choi HJ; Ryu JM; Kim I; Nam SJ; Kim SW; Yu J; Lee JE; Lee SK
    Ann Surg Treat Res; 2019 Apr; 96(4):169-176. PubMed ID: 30941320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients.
    Li Z; Tong Y; Chen X; Shen K
    Front Oncol; 2022; 12():845823. PubMed ID: 35936729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
    Maimaitiaili A; Chen H; Xie P; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; He J; Fan Z; Zhang H
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8769-8778. PubMed ID: 37129606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
    Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS
    Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multivariable model of ultrasound and clinicopathological features for predicting axillary nodal burden of breast cancer: potential to prevent unnecessary axillary lymph node dissection.
    Yang L; Gu Y; Wang B; Sun M; Zhang L; Shi L; Wang Y; Zhang Z; Yin Y
    BMC Cancer; 2023 Dec; 23(1):1264. PubMed ID: 38129804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete Response and Axillary Response in Node-Positive Patients with Triple- Negative Breast Cancer.
    Zhang M; Zha H; Pan J; Liu X; Zong M; Du L; Du Y
    Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38627192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients.
    Corsi F; Albasini S; Sorrentino L; Armatura G; Carolla C; Chiappa C; Combi F; Curcio A; Della Valle A; Ferrari G; Gasparri ML; Gentilini O; Ghilli M; Listorti C; Mancini S; Marinello P; Meani F; Mele S; Pertusati A; Roncella M; Rovera F; Sgarella A; Tazzioli G; Tognali D; Folli S
    Breast; 2021 Dec; 60():131-137. PubMed ID: 34624755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
    Kim WH; Kim HJ; Park HY; Park JY; Chae YS; Lee SM; Cho SH; Shin KM; Lee SY
    Ultrasound Med Biol; 2019 Mar; 45(3):702-709. PubMed ID: 30567630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
    Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
    Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An MRI-based Scoring System for Preoperative Prediction of Axillary Response to Neoadjuvant Chemotherapy in Node-Positive Breast Cancer: A Multicenter Retrospective Study.
    Huang X; Shi Z; Mai J; Liu C; Liu C; Chen S; Lu H; Li Y; He B; Li J; Cun H; Han C; Chen X; Liang C; Liu Z
    Acad Radiol; 2023 Jul; 30(7):1257-1269. PubMed ID: 36280517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Lai J; Pan Z; Chen P; Ye G; Chen K; Su F
    Jpn J Clin Oncol; 2019 Jan; 49(1):22-28. PubMed ID: 30508184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer.
    Huang JX; Lin SY; Ou Y; Shi CG; Zhong Y; Wei MJ; Pei XQ
    Eur Radiol; 2022 Sep; 32(9):5986-5996. PubMed ID: 35364714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer.
    Wang M; Wang M; Wang Z; Song Y; Gao P; Wang P; Wang C; Yu X; Wei F; Guo J; Xu Y
    Transl Cancer Res; 2020 Nov; 9(11):7054-7064. PubMed ID: 35117311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.